Principles of Metabolic Regulation

Metabolism is a living network that continuously adjusts to match the cell's moment-to-moment needs. The MCAT tests why certain enzymes are regulated, how signals propagate through a pathway, and what happens when you push on one end of the network.

Priority labels: Must know = cold; Know the logic = mechanism not names; Passage-level = recognize, don't memorize; Optional = skippable.

---

The Logic of Pathway Regulation

Must know

Cells regulate flux (the rate of metabolite flow through a pathway), not individual reactions in isolation. Pathways are controlled at committed steps—reactions that are essentially irreversible under cellular conditions and whose product has no fate but to continue down the pathway. Regulating a reversible (near-equilibrium) reaction would be futile.

Identifying Regulated Reactions

Must know

The thermodynamic marker of a regulated step is a large negative actual free energy change ($\Delta G$, not $\Delta G°'$). A reaction far from equilibrium ($Q \ll K_{eq}$) is effectively irreversible and is a control point; a reaction at equilibrium ($\Delta G \approx 0$) is not—its rate just follows substrate availability.

$\Delta G = \Delta G°' + RT \ln Q$

The three mechanisms cells use to change enzyme activity:

1. Allosteric regulation — small molecules bind non-active-site sites and change conformation. Fastest (milliseconds).
2. Covalent modification — usually phosphorylation by kinases/phosphatases. Rapid (seconds), hormonally triggered.
3. Transcriptional/translational — changing the amount of enzyme. Slowest (hours).

Allosteric and covalent regulation dominate on the MCAT.

Feedback (End-Product) Inhibition

Must know

In feedback inhibition, the final product of a pathway allosterically inhibits an enzyme catalyzing an early, committed step, shutting the pathway off once enough product accumulates. The logic is universal: regulate at the committed step, let the downstream product report back. Contrast with feed-forward activation, where an upstream intermediate stimulates a later enzyme (e.g., F1,6-BP activates pyruvate kinase).

Passage-level

CTP inhibits ATCase (pyrimidine synthesis); isoleucine inhibits threonine deaminase; within glycolysis, ATP and citrate inhibit PFK-1 and G6P inhibits hexokinase.

Quick check: Why is hexokinase a better regulatory target than phosphoglucose isomerase?

Answer: Hexokinase catalyzes a committed, essentially irreversible step. Phosphoglucose isomerase operates near equilibrium—regulating it would not meaningfully control flux.

---

Maintenance of a Dynamic Steady State

Must know

Cells are open systems—they import nutrients and export waste, holding metabolite concentrations roughly constant but never at thermodynamic equilibrium. This dynamic steady state maintains gradients, membrane potentials, and directional flux, all requiring ongoing energy input.

Energy Charge and Redox State as Metabolic Sensors

Know the logic

The key intracellular signals of energy status:

Signal	High value means…	Low value means…
ATP/ADP (or ATP/AMP)	Energy-replete; slow catabolism	Energy-depleted; accelerate catabolism
NADH/NAD⁺	Reducing equivalents plentiful	Need more oxidative substrate
F2,6-BP	Fed; drive glycolysis	Fasted; drive gluconeogenesis

The energy charge (EC) formally summarizes ATP status:

$EC = \frac{[\text{ATP}] + \frac{1}{2}[\text{ADP}]}{[\text{ATP}] + [\text{ADP}] + [\text{AMP}]}$

High EC (near 1.0) inhibits catabolism; low EC activates it. AMP is an especially sensitive crisis indicator: a modest ATP drop causes a large AMP rise via the adenylate kinase equilibrium ($\ce{2 ADP <=> ATP + AMP}$), amplifying the signal.

Quick check: A cell has [ATP] = 8 mM, [ADP] = 1 mM, [AMP] = 0.1 mM. Is energy charge high or low, and what about glycolysis?

Answer: $EC = (8 + 0.5)/9.1 \approx 0.93$. High → glycolysis inhibited (ATP inhibits PFK-1; low AMP means no AMP activation).

AMPK: The Master Energy Sensor

Must know

AMP-activated protein kinase (AMPK) is activated by a rising AMP/ATP ratio (the energy-crisis signal). Its single logic: switch ON catabolic, ATP-generating pathways and switch OFF anabolic, ATP-consuming ones—it turns on glucose uptake, glycolysis, and fatty acid oxidation, and turns off fatty acid, cholesterol, and glycogen synthesis.

Optional

AMPK inhibits acetyl-CoA carboxylase (ACC), lowering malonyl-CoA, which relieves CPT-1 inhibition and lets fatty acids enter mitochondria for oxidation.

---

Regulation of Glycolysis

Must know

Glycolysis converts one glucose to two pyruvate (net 2 ATP, 2 NADH). Its three irreversible steps—hexokinase (HK), phosphofructokinase-1 (PFK-1), and pyruvate kinase (PK)—are the control points.

Hexokinase vs. Glucokinase

Must know

Most tissues express hexokinase, which has a low $K_m$ for glucose and is product-inhibited by G6P—glucose import is capped at what downstream steps can handle.

The liver (and pancreatic β-cells) express glucokinase (GK, hexokinase IV) instead, with a high $K_m$ (~10 mM, active only when blood glucose is elevated after a meal), sigmoidal kinetics, and no G6P product inhibition. This makes glucokinase a glucose sensor—the liver traps glucose only when blood glucose is genuinely high, so it doesn't compete with the brain at low concentrations.

Optional

Glucokinase is inhibited by glucokinase regulatory protein (GKRP), which sequesters it in the nucleus; elevated glucose and fructose-1-phosphate release it.

PFK-1: The Master Valve of Glycolysis

Must know

PFK-1 converts F6P to F1,6-BP and is the major regulatory enzyme of glycolysis.

Activators of PFK-1	Inhibitors of PFK-1
AMP, ADP, F2,6-BP	ATP, citrate, H⁺ (low pH)

F2,6-BP is the most potent allosteric activator. Its level is set by the bifunctional enzyme PFK-2/FBPase-2:

• Insulin high (fed): PFK-2 active → F2,6-BP rises → glycolysis ON.
• Glucagon high (fasted): PKA phosphorylates the enzyme → FBPase-2 active → F2,6-BP falls → glycolysis OFF, gluconeogenesis ON.

Know the logic

Citrate signals the TCA cycle has enough substrate, so glycolysis slows. H⁺ inhibition prevents anaerobic glycolysis from runaway acidifying the cell.

Pyruvate Kinase

Know the logic

PK (PEP → pyruvate) is activated by F1,6-BP (feed-forward), inhibited by ATP and alanine, and—in liver—inhibited by glucagon via PKA phosphorylation.

Quick check (worked example): A muscle cell is exercising heavily: AMP rises, citrate is low, F2,6-BP moderate. Predict PFK-1 activity.

Answer: AMP activates, low citrate removes inhibition, F2,6-BP adds activation—PFK-1 is highly active, driving glycolysis to meet ATP demand.

---

Regulation of Gluconeogenesis

Must know

Gluconeogenesis (GNG) makes glucose in liver and kidney cortex from lactate (Cori cycle), glucogenic amino acids (esp. alanine), and glycerol.

GNG is not glycolysis in reverse—the three irreversible glycolytic steps are bypassed by four dedicated enzymes:

Glycolytic step (irreversible)	GNG bypass enzyme(s)
Pyruvate → PEP (PK)	Pyruvate carboxylase (→ OAA) + PEPCK (OAA → PEP)
F1,6-BP → F6P (PFK-1)	Fructose-1,6-bisphosphatase (FBPase-1)
G6P → glucose (HK)	Glucose-6-phosphatase (liver/kidney only)

Know the logic

Pyruvate carboxylase requires acetyl-CoA as an allosteric activator—high acetyl-CoA (from fatty-acid β-oxidation during fasting) signals the TCA cycle is carbon-saturated, so pyruvate should go to glucose.

Reciprocal regulation is the key concept: signals that activate glycolysis simultaneously inhibit GNG (F2,6-BP activates PFK-1 AND inhibits FBPase-1), preventing an ATP-wasting futile cycle.

The Cori Cycle

Passage-level

Muscle exports lactate to the liver, which reconverts it to glucose via GNG. The cycle is a net energy cost (6 ATP spent in liver vs. 2 ATP net gained in muscle), shifting the burden to hepatic oxidative metabolism.

Quick check: Why doesn't skeletal muscle perform gluconeogenesis?

Answer: Muscle lacks glucose-6-phosphatase—it cannot release free glucose to the blood. GNG for blood glucose is liver- and kidney-specific.

---

Metabolism of Glycogen

Must know

Glycogen is the glucose storage polymer, mainly in liver (for blood glucose) and muscle (local use only). Glucose units are linked by α-1,4 bonds in chains with α-1,6 branch points. Branches give many non-reducing ends, allowing rapid degradation/synthesis at many sites at once.

Glycogen Synthesis

Know the logic

1. G1P is activated to UDP-glucose: $\ce{G1P + UTP -> UDP-glucose + PPi}$; $\ce{PPi}$ hydrolysis drives it forward.
2. Glycogen synthase adds glucose to a chain's non-reducing end (α-1,4 bond).
3. Branching enzyme transfers a segment to form α-1,6 branch points.

Optional

Glycogenin is the self-glucosylating primer that nucleates new granules.

Glycogen Breakdown (Glycogenolysis)

Know the logic

1. Glycogen phosphorylase cleaves α-1,4 bonds phosphorolytically (uses Pi, not water—no ATP spent): $\ce{Glycogen_{(n)} + Pi -> Glycogen_{(n-1)} + G1P}$.
2. Debranching enzyme moves the branch stub and cleaves the α-1,6 bond, releasing free glucose (not G1P).
3. G1P → G6P via phosphoglucomutase. In muscle, G6P → glycolysis; in liver, G6Pase releases free glucose to blood.

Quick check: A patient with muscle glycogen phosphorylase deficiency (McArdle disease) has exercise intolerance. Predict the finding after ischemic forearm exercise.

Answer: Normally ischemic exercise raises blood lactate. Here glycogen can't be broken down, so muscle glycolysis is starved of G6P and lactate fails to rise—classic for McArdle disease.

---

Regulation of Glycogen Synthesis and Breakdown

Must know

Glycogen metabolism is under reciprocal regulation—when breakdown is ON, synthesis is OFF. Phosphorylation does both at once:

Enzyme	Effect of phosphorylation	Active form
Glycogen phosphorylase	Activates (phosphorylase a)	Phosphorylated
Glycogen synthase	Inactivates (synthase b)	Dephosphorylated

The Hormonal Cascade (Glucagon/Epinephrine → Breakdown)

Must know

One of the most testable MCAT cascades:

1. Glucagon (liver) or epinephrine (liver + muscle) binds a Gs-coupled GPCR.
2. Adenylyl cyclase → cAMP rises.
3. cAMP activates Protein Kinase A (PKA).
4. PKA activates phosphorylase kinase and directly inactivates glycogen synthase.
5. Phosphorylase kinase converts glycogen phosphorylase b → a (active).
6. Result: glycogen broken down, synthesis stopped.

Signal amplification is key—one glucagon molecule activates millions of phosphorylase molecules.

Insulin → Glycogen Synthesis

Know the logic

Insulin (RTK signaling) activates protein phosphatase 1 (PP1), which dephosphorylates phosphorylase (→ inactive) and glycogen synthase (→ active): synthesis ON, breakdown OFF.

Muscle-Specific Regulation by Ca²⁺ and AMP

Know the logic

In muscle, phosphorylase kinase has a calmodulin subunit, so $\ce{Ca^{2+}}$ released during contraction activates it directly (without PKA)—linking contraction to glycogenolysis. Muscle phosphorylase is also allosterically activated by AMP and inhibited by ATP and G6P.

Passage-level

In liver, glucose allosterically inhibits phosphorylase a (promoting its dephosphorylation by PP1)—glucose itself signals "stop releasing glucose."

Quick check (worked example): A patient receives epinephrine. Describe the molecular events in muscle over the next 30 seconds.

Answer: Epinephrine → β-adrenergic Gs GPCR → adenylyl cyclase → cAMP rises → PKA activated → phosphorylates phosphorylase kinase (→ activates phosphorylase b to a) and inactivates glycogen synthase → glycogen rapidly broken down to G1P → G6P → glycolysis, producing ATP for "fight or flight"; synthesis suspended.

---

Allosteric and Hormonal Control: Mechanisms in Depth

Allosteric Enzymes

Must know

Allosteric enzymes are usually multi-subunit and show sigmoidal kinetics rather than hyperbolic Michaelis-Menten. The Hill equation describes cooperativity:

$v = \frac{V_{max}[S]^n}{K_{0.5}^n + [S]^n}$

$n > 1$ indicates positive cooperativity, creating a switch-like response—low activity below a threshold, sharply rising above it.

Know the logic

Heterotropic effectors (molecules other than substrate): activators stabilize the R (active) state, increasing apparent affinity; inhibitors stabilize the T (inactive) state. This differs from classic competitive/non-competitive inhibition.

Optional

Two cooperativity models—concerted (MWC): all subunits flip together (T or R); sequential (KNF): subunits change one at a time. Know the concept; MWC is more commonly tested.

Second Messenger Systems

Must know

These are the abstract signal-transduction motifs that carry a hormonal signal to a target enzyme. The point here is the mechanism, not which hormone does what to which tissue—for the full hormonal and tissue-specific treatment (insulin, glucagon, epinephrine, cortisol, thyroid, GH), see the Metabolism (whole-body integration) guide.

cAMP pathway: A signal binds a GPCR ($G_s$) → adenylyl cyclase → $\ce{ATP -> cAMP}$ → PKA phosphorylates targets. cAMP is degraded by phosphodiesterase (inhibited by caffeine). Glucagon and epinephrine are the canonical examples of signals that raise cAMP.

RTK pathway: A signal binds a receptor tyrosine kinase → IRS → PI3K → Akt → effects including GLUT4 translocation, glycogen synthase activation (via PP1), PFK-2 activation, and suppression of gluconeogenic genes. Insulin is the canonical example.

Quick check: Why does a cAMP-mobilizing signal promote liver glycogenolysis but not muscle glycogen breakdown when that signal is glucagon?

Answer: Glucagon receptors are on hepatocytes but not skeletal muscle. Muscle glycogenolysis is triggered by epinephrine and local signals (AMP, Ca²⁺). The mechanism (Gs → cAMP → PKA) is identical; only the receptor distribution differs. (See the Metabolism integration guide for the full hormone-by-tissue map.)

---

Analysis of Metabolic Control

Must know

Intuition says "the slowest step controls flux," but the MCAT-level insight is that flux control is often distributed across several enzymes, though one regulated step usually dominates. The dominant enzyme typically (1) catalyzes the most thermodynamically irreversible step, (2) operates below $V_{max}$, and (3) is allosterically regulated. For glycolysis, that is PFK-1.

Near-Equilibrium vs. Non-Equilibrium Reactions

Must know

Property	Near-equilibrium	Non-equilibrium
$\Delta G$ in cell	≈ 0	Very negative
$Q/K_{eq}$	≈ 1	$\ll 1$
Role in regulation	Follows substrate	Major control point
Glycolysis example	Phosphoglucose isomerase	PFK-1

Quick check (numerical worked example): For PFK-1, $\Delta G°' = -14.2 \text{ kJ/mol}$. At [F6P] = 0.14 mM, [F1,6-BP] = 0.031 mM, [ATP] = 1.85 mM, [ADP] = 0.14 mM, calculate $\Delta G$ at 37°C.

Reaction: $\ce{F6P + ATP -> F1,6-BP + ADP}$.

$Q = \frac{[\text{F1,6-BP}][\text{ADP}]}{[\text{F6P}][\text{ATP}]} = \frac{(0.031)(0.14)}{(0.14)(1.85)} = 0.0168$

$\Delta G = -14.2 + (8.314 \times 10^{-3})(310)\ln(0.0168) = -14.2 - 10.5 = -24.7 \text{ kJ/mol}$

Answer: $\Delta G \approx -24.7 \text{ kJ/mol}$—much more negative than $\Delta G°'$ because $Q \ll K_{eq}$. This confirms PFK-1 is far from equilibrium and a genuine control point.

---

Common Confusions & Tricks

1. "Glucagon acts on muscle" — FALSE. Glucagon receptors are absent from skeletal muscle. Muscle glycogen breakdown is triggered by epinephrine and local signals (AMP, Ca²⁺).

2. Phosphorylation activates phosphorylase but inhibits glycogen synthase. PKA responds to "emergency" signals: release stored glucose (activate breakdown) and stop storing it (inactivate synthesis).

3. G1P vs. G6P from glycogen breakdown. Phosphorylase releases G1P; phosphoglucomutase converts it to G6P. Branch-point glucose from debranching enzyme is free glucose (must be phosphorylated by hexokinase, costing 1 ATP).

4. PFK-1 vs. PFK-2. PFK-1 catalyzes glycolysis (F6P → F1,6-BP). PFK-2 makes F2,6-BP, a regulator (not a glycolytic intermediate)—an allosteric activator of PFK-1, not its substrate.

5. F2,6-BP ≠ F1,6-BP. F2,6-BP (C2 and C6) is a regulatory molecule; F1,6-BP (C1 and C6) is the glycolytic intermediate.

6. "Rate-limiting step" = committed step. Related but not identical: committed = irreversibly enters the pathway; rate-limiting = slowest. For glycolysis PFK-1 is both, but don't assume this in every pathway.

7. Pyruvate carboxylase requires acetyl-CoA. For activated GNG, look for high acetyl-CoA (increased fat oxidation—fasting, diabetic ketoacidosis). Acetyl-CoA cannot become glucose but signals GNG should proceed.

8. Insulin receptor is an RTK; glucagon/epinephrine use GPCRs. Insulin → RTK → IRS → PI3K → Akt (NOT JAK/STAT, which is used by cytokine receptors). Glucagon/epinephrine → Gs GPCR → cAMP → PKA.

9. The Cori cycle is a net energy consumer. Liver spends 6 ATP to remake glucose that yielded only 2 ATP net in muscle—it loans glucose at hepatic energy expense.

10. "High AMP → activate catabolism." AMP activates PFK-1, glycogen phosphorylase, and AMPK (which activates fatty acid oxidation, inhibits its synthesis). AMP is the universal energy-crisis alarm.

---

Key Equations

Equation	Variables & Use
$\Delta G = \Delta G°' + RT \ln Q$	$\Delta G°'$: standard free energy; $Q$: mass-action ratio; $R = 8.314 \times 10^{-3}$ kJ/mol·K. Tells whether a reaction is at or far from equilibrium (control point).
$Q = \frac{[\text{products}]}{[\text{reactants}]}$	Mass-action ratio at actual cellular concentrations. If $Q \ll K_{eq}$, reaction runs forward.
$EC = \dfrac{[\text{ATP}] + \frac{1}{2}[\text{ADP}]}{[\text{ATP}] + [\text{ADP}] + [\text{AMP}]}$	Energy charge (0–1). High EC inhibits catabolism, activates anabolism.
$v = \dfrac{V_{max}[S]^n}{K_{0.5}^n + [S]^n}$	Hill equation for cooperative enzymes. $n > 1$ = positive cooperativity (sigmoid curve).
$\ce{F6P + ATP -> F1,6-BP + ADP}$	PFK-1; the major regulated step of glycolysis.
$\ce{Pyruvate + CO2 + ATP -> OAA + ADP + Pi}$	Pyruvate carboxylase; first GNG step; requires biotin and acetyl-CoA.
$\ce{Glycogen_{(n)} + Pi -> Glycogen_{(n-1)} + G1P}$	Glycogen phosphorylase (phosphorolysis—no ATP). Activated by phosphorylation and AMP.